News & Events
Dutch MS Research Foundation part of EUR 15 million research project
The ‘Immune balance’ partnership unites health charities, the government, scientists and corporate bodies in a joint effort…
MS Research Australia triumphs at national Charity Awards
MS Research Australia has been recognised for ‘Outstanding Achievement’ in the Australian Charity Awards 2018.
Dancing for MS: Portugal’s new awareness campaign
The Portuguese MS Society (SPEM) is calling on people nationwide to raise awareness of MS through dance…
Signs of MS may start five years before diagnosis
Canadian research shows people with MS are more likely than the general population to visit a doctor…
Study suggests improvement in MS employment outcomes
New research, involving 874 people who had used disease-modifying therapies during the previous 5 years, has shown…
Primary progressive MS risk may be linked to genes that cause other brain diseases
Genetic screening of people with primary progressive MS has shown that four rare genetic changes, which are…
‘Rings of fire’: blocking the death of brain cells in MS
A new study that suggests inflammation may lead to the death of brain cells in MS may…
New Zealand launches country’s first MS registry
The New Zealand Multiple Sclerosis Research Trust invited Professor Helmut Butzkueven, Managing Director of MSBase, to launch…
Highlights from the Cykelnerven cycling challenge
Daniel Magson, Fundraising Campaigns Manager at MSIF, shares the highlights from Cykelnerven, a new and unique charity…
ARSEP awards 1.6m EUR to MS research proposals
The Scientific Committee of the French MS Research Support Foundation (ARSEP) has selected recipients for its annual…
Over 20,000 people sign UK MS Society’s petition to improve disability benefit for people with MS
The UK MS Society’s campaign calls on the government to change criteria of Personal Independence Payments (PIP),…
Natalizumab treatment may preserve upper limb function in secondary progressive MS
Results from a trial of natalizumab in secondary progressive MS suggest anti-inflammatory treatments could slow disability accumulation,…